MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-GJ-01-0004737
Asterin Pharmaceuticals Private Limited
Asterin Pharmaceuticals Private Limited - pharma in Ahmedabad, Gujarat, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹1.26 Cr
▲ 9% YoY
Net profit · FY 2025
₹1.03 Lakh
Net margin 0.8%
EBITDA · FY 2025
₹9.16 Lakh
EBITDA margin 7.3%
Authorised capital
₹25 Lakh
Registered with MCA
Paid-up capital
₹8 Lakh
Issued & subscribed
Open charges
₹40 Lakh
Secured borrowings
Company age
6 yrs
Est. 2020
Directors on board
4
As per MCA filings
About Asterin Pharmaceuticals Private Limited
Data last updated:
Asterin Pharmaceuticals Private Limited is a private limited company based in Ahmedabad, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 19 July 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24299GJ2020PTC114791. Its GSTIN is 24AATCA7137Q1ZW (Gujarat).
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹8 Lakh. It is led by directors including Tanvirsinh Rathod Bhavanisinh and Jayantilal Ranchhodbhai Patel.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Ahmedabad, Gujarat.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.26 Cr, a growth of 9% compared to the previous year. For the same year it recorded a net profit of ₹1.03 Lakh (net margin 0.8%) and EBITDA of ₹9.16 Lakh (EBITDA margin 7.3%). Revenue has grown at a compounded annual rate (CAGR) of 16% over three years.
As per MCA filings, the company has open charges of ₹40 Lakh on record.
Asterin Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-01-0004737). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24299GJ2020PTC114791
Registration Number 114791
Incorporation Date 19 July 2020
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-GJ-01-0004737
Key People
Tanvirsinh Rathod Bhavanisinh Director Jayantilal Ranchhodbhai Patel Director Amrish Nareshbhai Solanki Director Recognitions & Rankings of Asterin Pharmaceuticals
Contact details
Asterin Pharmaceuticals Private Limited's registered office is in Ahmedabad, Gujarat. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address135 Sun Gravitas, Radio Mirchi Road Vejalpur, Ahmedabad, Gujarat, India – 380051
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Asterin Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Asterin Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Asterin Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Asterin Pharmaceuticals Private Limited, buy the company report.
Financials of Asterin Pharmaceuticals Private Limited
FY 2025 filings availableAsterin Pharmaceuticals Private Limited reported revenue of ₹1.26 Cr (up 9% YoY) for FY 2025.
Revenue · FY 2025
₹1.26 Cr ▲ 9%
Net profit · FY 2025
₹1.03 Lakh margin 0.8%
EBITDA · FY 2025
₹9.16 Lakh margin 7.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 9%
3 years · compounded
▲ 16%
EBITDA CAGR growth
1 year
▲ 70%
3 years · compounded
▲ 42%
Revenue has grown at a compounded annual rate (CAGR) of 16% over three years, including 9% growth in the latest year. EBITDA rose 70% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹9.16 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.03 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.3% | ||||
| Net Profit Margin | 0.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Asterin Pharmaceuticals Private Limited, buy the company report.
Board of directors of Asterin Pharmaceuticals Private Limited
Asterin Pharmaceuticals has 4 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Tanvirsinh Rathod Bhavanisinh | Director | 19 Jul 2020 | 6 Years 3 Months | Current |
| Jayantilal Ranchhodbhai Patel | Director | 19 Jul 2020 | 6 Years 3 Months | Current |
| Amrish Nareshbhai Solanki | Director | 19 Jul 2020 | 6 Years 3 Months | Current |
| Himanshu Ghanshyam Acharya | Director | 19 Jul 2020 | 6 Years 3 Months | Current |
Peer comparison
Asterin Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Symantec Health Care Private Limited | ₹1.26 Cr (FY 2024) | -59.0% | Thane, Maharashtra, India | |||
| Omni Laboratories Private Limited | ₹1.26 Cr (FY 2025) | -11.0% | New Delhi, Delhi, India | |||
| Dehlvi Remedies Private Limited | ₹1.26 Cr (FY 2024) | 32.0% | New Delhi, Delhi, India | |||
| Asterin Pharmaceuticals Private Limitedthis company | ₹1.26 Cr (FY 2025) | ₹1.03 Lakh | 0.8% | 9.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Asterin Pharmaceuticals Private Limited, buy the company report.
Auditor
Asterin Pharmaceuticals Private Limited is audited by Priyank P Patel And Co. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Priyank P Patel And Co. | FY 2023 | 141395W |
Shareholding
The shareholding of Asterin Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Asterin Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹40 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 10 Oct 2024 | 100997934 | Others | ₹40 Lakh | Open |
To see the full charge records of Asterin Pharmaceuticals Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Asterin Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Asterin Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Asterin Pharmaceuticals Private Limited has 1 active EPFO establishment as of Nov 11, 2026.
Active EPFO establishments
1
GST
Asterin Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AATCA7137Q1ZW | Gujarat | Active | 30 Jul 2020 |
To see the full GST registrations and return filing status of Asterin Pharmaceuticals Private Limited, buy the company report.
Recent activity
Asterin Pharmaceuticals Private Limited has 4 board changes on record since 2020: 4 appointments. The latest: Amrish Nareshbhai Solanki was appointed as Director on 19 Jul 2020.
Charges
A charge with Others of Rs. 40.00 Lakh registered on 10 Oct 2024 with Charge ID 100997934 was modified on 12 Jan 2026.
AGM
Asterin Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Asterin Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Charges
A charge with Others amounted to Rs. 40.00 Lakh with Charge ID 100997934 was registered on 10 Oct 2024.
Appointed
Amrish Nareshbhai Solanki was appointed as Director.
Appointed
Himanshu Ghanshyam Acharya was appointed as Director.
Appointed
Jayantilal Ranchhodbhai Patel was appointed as Director.
Appointed
Tanvirsinh Rathod Bhavanisinh was appointed as Director.
Incorporation
19 Jul 2020
Asterin Pharmaceuticals Private Limited was registered on 19 Jul 2020 with Roc Ahmedabad & aged 6 years 3 months as per MCA records.
Frequently asked questions
Asterin Pharmaceuticals is an active private limited company based in Ahmedabad, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 19 July 2020 (6+ years old) and is registered under CIN U24299GJ2020PTC114791.
Asterin Pharmaceuticals has 4 current directors:
- Tanvirsinh Rathod Bhavanisinh - Director
- Jayantilal Ranchhodbhai Patel - Director
- Amrish Nareshbhai Solanki - Director
- Himanshu Ghanshyam Acharya - Director
The latest financial statements of Asterin Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Asterin Pharmaceuticals is 24AATCA7137Q1ZW, registered in Gujarat.
The CIN (Corporate Identification Number) of Asterin Pharmaceuticals is U24299GJ2020PTC114791. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Asterin Pharmaceuticals was incorporated on 19 July 2020, making it 6+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Asterin Pharmaceuticals by revenue are Symantec Health Care Private Limited, Omni Laboratories Private Limited, Dehlvi Remedies Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Amrish Nareshbhai Solanki was appointed as Director on 19 Jul 2020. Himanshu Ghanshyam Acharya was appointed as Director on 19 Jul 2020. Jayantilal Ranchhodbhai Patel was appointed as Director on 19 Jul 2020. Asterin Pharmaceuticals has 4 board changes on record in total.
Yes, Asterin Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-GJ-01-0004737).
The registered office of Asterin Pharmaceuticals is at 135 Sun Gravitas, Radio Mirchi Road Vejalpur, Ahmedabad, Gujarat, India – 380051.
Asterin Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages